Somewhat Positive Media Coverage Somewhat Unlikely to Affect MCBC (MCFT) Share Price

Share on StockTwits

News coverage about MCBC (NASDAQ:MCFT) has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. MCBC earned a news sentiment score of 0.24 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.3964814763344 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

A number of research firms have weighed in on MCFT. Robert W. Baird raised their price target on MCBC from $24.00 to $29.00 and gave the company an “outperform” rating in a research note on Friday, February 9th. BidaskClub upgraded MCBC from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 9th. B. Riley raised their price target on MCBC from $28.00 to $29.25 and gave the company a “buy” rating in a research note on Friday, February 9th. ValuEngine cut MCBC from a “buy” rating to a “hold” rating in a research note on Monday. Finally, Zacks Investment Research upgraded MCBC from a “hold” rating to a “buy” rating and set a $28.00 price target on the stock in a research note on Wednesday, February 14th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. MCBC presently has an average rating of “Buy” and a consensus price target of $28.06.

Shares of MCFT traded up $0.23 during midday trading on Thursday, reaching $25.14. 106,500 shares of the stock were exchanged, compared to its average volume of 190,774. The company has a debt-to-equity ratio of 3.29, a quick ratio of 0.23 and a current ratio of 0.62. MCBC has a twelve month low of $15.58 and a twelve month high of $28.62. The stock has a market capitalization of $458.95, a P/E ratio of 19.95, a price-to-earnings-growth ratio of 0.91 and a beta of 1.13.

MCBC (NASDAQ:MCFT) last posted its earnings results on Thursday, February 8th. The company reported $0.42 EPS for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.09. MCBC had a return on equity of 149.34% and a net margin of 9.07%. The business had revenue of $78.40 million for the quarter, compared to analysts’ expectations of $74.65 million. During the same quarter in the previous year, the firm earned $0.26 earnings per share. The business’s revenue was up 53.4% compared to the same quarter last year. equities research analysts forecast that MCBC will post 1.79 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Affect MCBC (MCFT) Share Price” was originally posted by BBNS and is owned by of BBNS. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://baseballnewssource.com/2018/04/05/mcbc-mcft-earning-somewhat-favorable-press-coverage-report-finds/2027534.html.

MCBC Company Profile

MCBC Holdings, Inc (MCBC) is a holding company. The Company is a designer and manufacturer of inboard tournament ski boats and V-drive runabouts under the MasterCraft brand. The Company operates through two segments: MasterCraft and Hydra-Sports. The MasterCraft product brand consists of recreational performance boats primarily used for water skiing, wakeboarding and wake surfing, and general recreational boating.

Insider Buying and Selling by Quarter for MCBC (NASDAQ:MCFT)

Receive News & Ratings for MCBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MCBC and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.